About Liora Bioinformatics

Our story

Our roots lie within the small but excellent Furtwangen University (HFU) situated in the Black Forest area in Germany. Our founders met at a the Data Science for Life Science research group of the Institute of Precision Medicine. Collaborating with manifold international scientists and research groups we have encountered numerous data challenges. Shared passion for data science in life sciences and extensive demand on bioinformatics solutions led us to assemble a platform that allowed us to widen our impact beyond academia. In the year 2025 we founded this platform and named it Liora Bioinformatics.

Prof. Matthias Kohl, Ph.D.

Senior Scientific Advisor

Matthias Kohl, a renowned expert in mathematics for biology and medicine, leads our statistical and data science initiatives. In addition to successfully leading multiple research projects and advising clinicians and researchers, he authored several books on statistics and programming and maintains a portfolio of over 30 software packages. Alongside his role at Liora Bioinformatics, he serves as a professor at Furtwangen University, where he leads a research group at the Institute of Precision Medicine and directs the Steinbeis Transfer Center for Personalized Medicine.

Filip Paskali, M.D., M.Sc.

Chief Technology Officer

Filip Paskali, a medical scientist and data analyst, bridges the fields of biomedical research and scientific computing. With a background in general medicine and a PhD focus in biomedical image analysis, he develops interactive research applications, analytical tools, and reproducible workflows using R and Python. At Liora Bioinformatics he provides technical consulting and software development combining domain knowledge with hands-on data science and Linux expertise to support diverse research teams.

Marian Freisleben, M.Sc.

Chief Executive Officer

Marian Freisleben brings a multifaceted passion for science, technology, and innovation to his leadership role. He has a background in personalized medicine and bioinformatics and has successfully completed projects both in the lab and behind the keyboard, including work in high-throughput drug discovery and microbial genomics. His interdisciplinary mindset and commitment to impactful research help shape the company’s direction at the intersection of data-driven science and real-world applications.